Ronald B. Herberman, MD, the first director (currently director emeritus) of the University of Pittsburgh Cancer Institute, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, is an internationally recognized tumor immunologist who has made major discoveries in his field and has fostered the application of this information to novel approaches to cancer therapy.

For Dr. Herberman’s complete biography, please visit

http://www.upmccancercenters.com/about/bio-herberman.html

For complete lecture, please visit

http://www.pitt.edu/~super1/lecture/lec34291/004.htm